Final five-year results from the ENDEAVOR III trial, comparing the Endeavor Zotarolimus-Eluting Coronary Stent to the Cypher Sirolimus-Eluting Coronary Stent, showed Endeavor had lower long-term rates of adverse events, cardiovascular death and heart attacks. The results were released last week during the American College of Cardiology’s 59th Scientific Session.
The GuideLiner catheter is a coaxial “mother and child” guide extension using a rapid exchange system that provides back-up support and selective deep intubation in challenging coronary interventions. The catheter is available in 6, 7 and 8 French sizes.
A new and improved design of the original Gopher catheter, the Gopher Gold is designed for use when treating coronary and peripheral stenoses over an existing in-place 0.014-inch guide wire.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The Merit Laureate hydrophilic guide wire is designed for drainage catheter access, dialysis catheter placement, as well as difficult vascular access procedures.
March 24, 2010 – A team of Mayo Clinic researchers found that cardiac rehabilitation is associated with significantly reduced mortality rates for patients who receive coronary stents. The findings were presented last week at the annual meeting of the American College of Cardiology in Atlanta.
March 24, 2010 – Enrollment began this week in the CITADEL, which is the second of two large-scale, prospective, multicenter studies comparing implantable electrophysiology device infection rates. The study will look at patients with and without a new anti-bacterial envelope covering their devices.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 23, 2010 – Frost and Sullivan gave a 2010 North American New Product Innovation Award to Positron Corp. for its pioneering cardiac positron emission tomography (PET) scanner, the Attrius.
March 24, 2010 – The 2010 Annual Meeting of the American Association for Thoracic Surgery (AATS) will showcase two multipurpose interventional operating room suites that integrate digital imaging diagnostics, catheterization, and surgical capabilities.
March 18, 2010 – The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 23, 2010 – The U.S. Food and Drug Administration (FDA) recently added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
March 18, 2010 — A cardiac cryoablation catheter system designed for patients with paroxysmal atrial fibrillation (PAF) has completed premarket approval and is under review by the U.S. Food and Drug Administration (FDA).
March 23, 2010 - When imaging the brain, time is critical as vascular abnormalities can have a profound effect on patients’ lives if not diagnosed quickly. A new tool aims to help healthcare facilities diagnose disease with greater accuracy and speed when doing an magnetic resonance angiography study (MRA) on the brain.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 23, 2010 – A femoral access delivery system to aid physicians placing inferior vena cava (IVC) filters was introduced last week at the Society of Interventional Radiology (SIR) Annual Scientific Meeting.
March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's Cardizem LA product.
March 23, 2010 – At ACC last week Medtronic launched the Every Patient First health equity initiative, in partnership with healthcare providers, and professional societies, to reduce disparities in access to healthcare in the United States.
March 24, 2010
